If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,592.00    -32.00 (-1.22%)
Bid:
2,801.00
Ask:
2,463.00
Spread: -338.00 (-12.067%)
Market Cap: £26.06b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Interest in bond buy-backs

7 Sep 2016 09:30

RNS Number : 1840J
3i Group PLC
07 September 2016
 

Interest in bond buy-backs

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR TO ANY U.S. PERSON, OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT

 

07 September 2016

3i Group plc (the "Company") stated today that it continues to operate a purchase programme (the "Programme") pursuant to which the Company may from time to time purchase, through open market purchases or private transactions the following securities (the "Notes"):

Description of the Notes

Amount O/S

€350,000,000 5.625% Notes due 17 March 2017 XS0495913229

€ 313,192,000

 

The Company will decide in its sole discretion the total amount of Notes repurchased under the Programme. The price of a particular buy-back under the Programme is to be determined between the Company and relevant Noteholder.

Any Notes repurchased by the Company under the Programme will be cancelled.

The Programme is being carried out to manage liquidity in advance of the bond being repaid from existing cash reserves.

 

 

Requests for information in relation to the Programme should be directed to:

Deutsche Bank AG, London Branch

Winchester House

1 Great Winchester Street

London EC2N 2DB

United Kingdom

Telephone: +44 (0) 207 545 8011

 

 

 

DISCLAIMER

This announcement contains important information, which should be read carefully before any decision is made. If you are in doubt as to the action you should take, you are recommended to seek your own financial advice, including as to any tax consequences, from your stockbroker, bank manager, solicitor, accountant or other independent financial, tax or legal advisor. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to sell such Notes. None of the Company [or Deutsche Bank] makes any recommendation whether Noteholders should sell Notes.

 

OFFER AND DISTRIBUTION RESTRICTIONS

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required by the Company [and Deutsche Bank] to inform themselves about and to observe any such restrictions. This announcement does not constitute an offer to buy or a solicitation of an offer to sell the Notes (and offers to sell Notes will not be accepted from Noteholders) in any circumstances in which such offer or solicitation is unlawful.

 

United States:

No Offer to purchase Notes is being made or will be made, directly or indirectly, in or into, or by use of the mails of, or by any means or instrumentality of interstate or foreign commerce of, or of any facilities of a national securities exchange of, the United States. This includes, but is not limited to, facsimile transmission, electronic mail, telex, telephone, the internet and other forms of electronic communication. No Notes may be tendered by any such use, means, instrumentality or facility from or within the United States or by persons located or resident in the United States. Accordingly, copies of this announcement and any other documents or materials relating to the Notes are not being, and must not be, directly or indirectly, mailed or otherwise transmitted, distributed or forwarded (including, without limitation, by custodians, nominees or trustees) in or into the United States or to any U.S. persons or any persons located or resident in the United States. Any purported tender of Notes resulting directly or indirectly from a violation of these restrictions will be invalid and any purported tender of Notes made by a person located in the United States or any agent, fiduciary or other intermediary acting on a non-discretionary basis for a principal giving instructions from within the United States will be invalid and will not be accepted. Each holder of Notes that tenders Notes for purchase will be deemed to represent that it is not a U.S. person, it is not located in the United States and is not participating from the United States or it is acting on a non-discretionary basis for a principal that is not a U.S. person, that is located outside the United States and that is not giving an order to participate from the United States. For the purposes of this paragraph, United States means the United States of America, its territories and possessions, any state of the United States of America and the District of Columbia.

United Kingdom:

In the United Kingdom, this announcement is being distributed only to, and is directed only at persons whose ordinary activities involve them in acquiring, holding, managing or disposing of investments (as principal or agent) for the purposes of their business or who it is reasonable to expect will acquire, hold, manage or dispose of investments (as principal or agent) for the purposes of their business, for the purposes of Section 19 the Financial Services and Markets Act.

 

Japan:

 

The Notes are not registered under the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended, the "FIEL"). No offer to purchase Notes is being made or will be made, directly or indirectly, in Japan or to, or for the benefit of any resident of Japan (being any person resident in Japan, including any corporation or other entity organised under the laws of Japan) except where the Notes are held pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the FIEL and any other applicable laws, regulations and ministerial guidelines of Japan. Each holder of Notes that tenders Notes for purchase from Japan will be deemed to represent that the Notes are held in such a manner and pursuant to such an exemption.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUBUBUPQURM
Date   Source Headline
6th Jul 20267:00 amRNSTransaction in Own Shares
1st Jul 202611:19 amRNSDirector/PDMR Shareholding
30th Jun 20263:38 pmRNSTotal Voting Rights
30th Jun 20263:34 pmRNSAdmission to Trading
30th Jun 202612:00 pmRNSDirector/PDMR Shareholding
29th Jun 20267:00 amRNSTransaction in Own Shares
25th Jun 20263:31 pmRNSDirectorate change
25th Jun 20263:28 pmRNSDoc re. AGM Resolutions
25th Jun 20263:23 pmRNSResult of AGM
25th Jun 20267:00 amRNSAGM and portfolio update
22nd Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 202611:21 amRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20264:24 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:37 pmRNSDirector/PDMR Shareholding - Amendment
1st Jun 20264:28 pmRNSDirector/PDMR Shareholding
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:42 pmRNSTotal Voting Rights
29th May 20265:38 pmRNSAdmission to Trading
27th May 202610:42 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 202612:29 pmRNSDirector/PDMR Shareholding
21st May 20267:40 amRNSDoc re. 2026 Annual Report and Accounts
19th May 20262:28 pmRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:24 amRNSDirector/PDMR Shareholding
14th May 202610:41 amRNSHolding(s) in Company
14th May 20267:02 amRNSCommencement of Share Buyback Programme
14th May 20267:00 amRNSResults for the year to 31 March 2026
1st May 202612:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:34 pmRNSTotal Voting Rights
30th Apr 20263:31 pmRNSAdmission to Trading
7th Apr 202612:33 pmRNSHolding(s) in Company
1st Apr 20269:53 amRNSPortfolio Update
1st Apr 20269:36 amRNSDirector/PDMR Shareholding
31st Mar 20262:30 pmRNSTotal Voting Rights
31st Mar 20262:29 pmRNSAdmission to Trading
31st Mar 202611:37 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:07 pmRNSAdmission to Trading
26th Mar 20267:00 amRNSAction Capital Markets Seminar & portfolio update
23rd Mar 202612:11 pmRNSHolding(s) in Company
2nd Mar 202612:18 pmRNSDirector/PDMR Shareholding
27th Feb 20264:00 pmRNSTotal Voting Rights
3rd Feb 202610:20 amRNSHolding(s) in Company
3rd Feb 202610:17 amRNSDirector Declaration
30th Jan 20262:24 pmRNSDirector/PDMR Shareholding
30th Jan 20261:47 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.